Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease

The search for a convenient procedure to detect one of the earliest signs of Alzheimer's disease: A systematic review of the prediction of brain amyloid status

(2021) Miriam T. Ashford et al.   Alzheimers & Dementia

Four distinct trajectories of tau deposition identified in Alzheimer’s disease

(2021) Jacob W. Vogel et al.   NATURE MEDICINE

Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease‐informed machine‐learning

(2020) Nicolai Franzmeier et al.   Alzheimers & Dementia

Amyloid-β Positivity Predicts Cognitive Decline but Cognition Predicts Progression to Amyloid-β Positivity

(2020) Jeremy A. Elman et al.   BIOLOGICAL PSYCHIATRY

Cognitive reserve predicts future executive function decline in older adults with Alzheimer's disease pathology but not age-associated pathology

(2020) Cathryn McKenzie et al.   NEUROBIOLOGY OF AGING

FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

(2020) Tingxiang Yan et al.   Nature Communications

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

(2020) Nicolai Franzmeier et al.   Nature Communications

Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome

(2020) Matthias Arnold et al.   Nature Communications

Prediction of Alzheimer’s disease using blood gene expression data

(2020) Taesic Lee et al.   Scientific Reports

Novel Alzheimer’s disease subtypes identified using a data and knowledge driven strategy

(2020) Alexis Mitelpunkt et al.   Scientific Reports

Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography

(2020) Pierre-François Meyer et al.   JAMA Neurology

PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment

(2020) Luca Kleineidam et al.   ACTA NEUROPATHOLOGICA

Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification

(2020) Shangran Qiu et al.   BRAIN

Amyloid β-protein and beyond: the path forward in Alzheimer’s disease

(2020) Dominic M Walsh et al.   CURRENT OPINION IN NEUROBIOLOGY

Association of Cerebral Microbleeds with Cognitive Decline: A Longitudinal Study

(2020) Lin Li et al.   JOURNAL OF ALZHEIMERS DISEASE

What works and what does not work in Alzheimer’s disease? From interventions on risk factors to anti‐amyloid trials

(2020) Szofia Bullain et al.   JOURNAL OF NEUROCHEMISTRY

APOEε4 potentiates the relationship between amyloid-β and tau pathologies

(2020) Joseph Therriault et al.   MOLECULAR PSYCHIATRY

Serum triglycerides in Alzheimer disease

(2020) Megan M. Bernath et al.   NEUROLOGY

Detecting earlier stages of amyloid deposition using PET in cognitively normal elderly adults

(2020) Tengfei Guo et al.   NEUROLOGY

Patterns of longitudinal cortical atrophy over 3 years in empirically derived MCI subtypes

(2020) Emily C. Edmonds et al.   NEUROLOGY

Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

(2020) Jacob W. Vogel et al.   Nature Communications

Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia

(2020) Meng-Shan Tan et al.   Alzheimers Research & Therapy

Influence of Hypertension on Longitudinal Changes in Brain Glucose Metabolism Was Modified by the APOE4 Allele Among Cognitively Normal Older Individuals

(2020) Rui Zhou et al.   Frontiers in Aging Neuroscience

Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau

(2020) Mitchel A. Kling et al.   Alzheimers & Dementia

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation

(2020) Michael Ewers et al.   EMBO Molecular Medicine

The role of innate immunity in Alzheimer's disease

(2020) Hannah E. Ennerfelt et al.   IMMUNOLOGICAL REVIEWS

CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's disease

(2020) Phoebe Walsh et al.   NEUROBIOLOGY OF AGING

Multi-tracer model for staging cortical amyloid deposition using PET imaging

(2020) Lyduine E. Collij et al.   NEUROLOGY

Association of CSF Aβ, amyloid PET and cognition in cognitively unimpaired elderly adults

(2020) Tengfei Guo et al.   NEUROLOGY

The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease

(2020) Christoforos Hadjichrysanthou et al.   Alzheimers Research & Therapy

Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis

(2020) Eddie C. Stage et al.   Alzheimers Research & Therapy

Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval

(2020) Martin Tolar et al.   Alzheimers Research & Therapy

The Aging Slopes of Brain Structures Vary by Ethnicity and Sex: Evidence From a Large Magnetic Resonance Imaging Dataset From a Single Scanner of Cognitively Healthy Elderly People in Korea

(2020) Yu Yong Choi et al.   Frontiers in Aging Neuroscience

Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease

(2020) Neha S. Raghavan et al.   JAMA Neurology

Sex differences in Alzheimer’s-related Tau biomarkers and a mediating effect of testosterone

(2020) Erin E. Sundermann et al.   Biology of Sex Differences

Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline

(2020) Rachel F. Buckley et al.   ANNALS OF NEUROLOGY

Genetic variants and functional pathways associated with resilience to Alzheimer’s disease

(2020) Logan Dumitrescu et al.   BRAIN

Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration

(2020) Nicolai Franzmeier et al.   Molecular Neurodegeneration

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative

(2020) Thomas K. Karikari et al.   MOLECULAR PSYCHIATRY

Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease

(2020) Hui Wang et al.   NEUROBIOLOGY OF AGING

Age-dependent effect of APOE and polygenic component on Alzheimer's disease

(2020) Eftychia Bellou et al.   NEUROBIOLOGY OF AGING

White matter hyperintensities are associated with subthreshold amyloid accumulation

(2020) Alexis Moscoso et al.   NEUROIMAGE

Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment

(2020) David S. Knopman et al.   JAMA Neurology

Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics

(2020) Betty M Tijms et al.   BRAIN

Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer’s disease

(2020) Andréa L Benedet et al.   BRAIN

Time course of phosphorylated-tau181 in blood across the Alzheimer’s disease spectrum

(2020) Alexis Moscoso et al.   BRAIN

Association of TDP-43 Pathology with Global and Regional 18F-Florbetapir PET Signal in the Alzheimer’s Disease Spectrum

(2020) Stefan J. Teipel et al.   JOURNAL OF ALZHEIMERS DISEASE

The age-dependent associations of white matter hyperintensities and neurofilament light in early- and late-stage Alzheimer's disease

(2020) Phoebe Walsh et al.   NEUROBIOLOGY OF AGING

Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology

(2019) Marc Suárez-Calvet et al.   Molecular Neurodegeneration

Effect of age, ethnicity, sex, cognitive status and APOE genotype on amyloid load and the threshold for amyloid positivity

(2019) R. Duara et al.   NeuroImage-Clinical

Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured By Positron Emission Tomography in Clinically Normal Older Adults

(2019) Rachel F. Buckley et al.   JAMA Neurology

Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers

(2019) Gemma Salvadó et al.   Alzheimers Research & Therapy

Revealing heterogeneity of brain imaging phenotypes in Alzheimer’s disease based on unsupervised clustering of blood marker profiles

(2019) Gerard Martí-Juan et al.   PLoS One

Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults.

(2019) Katherine J. Bangen et al.   NEUROPSYCHOLOGY

Type 2 diabetes mellitus, brain atrophy, and cognitive decline

(2019) Chris Moran et al.   NEUROLOGY

The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies

(2019) Eider M Arenaza-Urquijo et al.   BRAIN

Early versus late MCI: Improved MCI staging using a neuropsychological approach

(2019) Emily C. Edmonds et al.   Alzheimers & Dementia

Predicting progression from mild cognitive impairment to Alzheimer’s disease on an individual subject basis by applying the CARE index across different independent cohorts

(2019) Jiu Chen et al.   Aging-US

Connectivity and morphology of hubs of the cerebral structural connectome are associated with brain resilience in AD- and age-related pathology

(2019) Florian U. Fischer et al.   Brain Imaging and Behavior

DIVE: A spatiotemporal progression model of brain pathology in neurodegenerative disorders

(2019) Răzvan V. Marinescu et al.   NEUROIMAGE

Personalized risk for clinical progression in cognitively normal subjects—the ABIDE project

(2019) Ingrid S. van Maurik et al.   Alzheimers Research & Therapy

Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease

(2019) Niklas Mattsson et al.   JAMA Neurology

A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal magnetic resonance imaging data

(2019) Hongming Li et al.   Alzheimers & Dementia

Genetic risk for Alzheimer's disease is distinct from genetic risk for amyloid deposition

(2019) Ganna Leonenko et al.   ANNALS OF NEUROLOGY

Combined Biomarker Prognosis of Mild Cognitive Impairment: An 11-Year Follow-Up Study in the Alzheimer’s Disease Neuroimaging Initiative

(2019) Barbara E. Spencer et al.   JOURNAL OF ALZHEIMERS DISEASE

Multi-modal latent factor exploration of atrophy, cognitive and tau heterogeneity in Alzheimer's disease

(2019) Nanbo Sun et al.   NEUROIMAGE

Determining clinically meaningful decline in preclinical Alzheimer disease

(2019) Philip S. Insel et al.   NEUROLOGY

Left frontal connectivity attenuates the adverse effect of entorhinal tau pathology on memory

(2019) Julia Neitzel et al.   NEUROLOGY

Cognitive reserve and clinical progression in Alzheimer disease

(2019) Anna Catharina van Loenhoud et al.   NEUROLOGY

Aβ-induced vulnerability propagates via the brain’s default mode network

(2019) Tharick A. Pascoal et al.   Nature Communications

Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography

(2019) Niklas Mattsson et al.   JAMA Neurology

Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology

(2019) Pierre-François Meyer et al.   Alzheimers & Dementia

In vivo measures of tau burden are associated with atrophy in early Braak stage medial temporal lobe regions in amyloid-negative individuals

(2019) Sandhitsu R. Das et al.   Alzheimers & Dementia

Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a “gray zone”?

(2019) Kevin McRae-McKee et al.   Alzheimers & Dementia

A model of brain morphological changes related to aging and Alzheimer's disease from cross-sectional assessments

(2019) Raphaël Sivera et al.   NEUROIMAGE

APOE ɛ4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia

(2019) Saira Saeed Mirza et al.   NEUROLOGY

Deep Learning in Alzheimer's Disease: Diagnostic Classification and Prognostic Prediction Using Neuroimaging Data

(2019) Taeho Jo et al.   Frontiers in Aging Neuroscience

Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD

(2019) Kathryn V. Papp et al.   Alzheimers & Dementia

White Matter Integrity Is Associated With Intraindividual Variability in Neuropsychological Test Performance in Healthy Older Adults

(2019) Drew W. R. Halliday et al.   Frontiers in Human Neuroscience

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

(2019) Ingrid S van Maurik et al.   LANCET NEUROLOGY

Regional brain atrophy predicts time to conversion to Alzheimer's disease, dependent on baseline volume

(2019) Hossein Tabatabaei-Jafari et al.   NEUROBIOLOGY OF AGING

Participant and study partner prediction and identification of cognitive impairment in preclinical Alzheimer’s disease: study partner vs. participant accuracy

(2019) Mary M. Ryan et al.   Alzheimers Research & Therapy

Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts

(2019) Lisa St. John-Williams et al.   Scientific Data

Study partner‐reported decline identifies cognitive decline and dementia risk

(2019) Rachel L. Nosheny et al.   Annals of Clinical and Translational Neurology

Blood and brain gene expression trajectories mirror neuropathology and clinical deterioration in neurodegeneration

(2019) Yasser Iturria-Medina et al.   BRAIN

Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study

(2019) Yan-Li Wang et al.   JOURNAL OF ALZHEIMERS DISEASE

Identifying Mild Cognitive Impairment with Random Forest by Integrating Multiple MRI Morphological Metrics

(2019) Zhe Ma et al.   JOURNAL OF ALZHEIMERS DISEASE

Predicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques

(2019) Ali Ezzati et al.   JOURNAL OF ALZHEIMERS DISEASE

Education does not protect cognitive function from brain pathology in the ADNI 2 cohort

(2019) Christopher E. Bauer et al.   NEUROBIOLOGY OF AGING

Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration

(2019) Kelsey R. Thomas et al.   NEUROLOGY

Associations of cigarette smoking with memory decline and neurodegeneration among cognitively normal older individuals

(2019) Peiliang Wu et al.   NEUROSCIENCE LETTERS

Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays

(2019) Kaj Blennow et al.   Scientific Reports

Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials

(2018) Takeshi Iwatsubo et al.   Alzheimers & Dementia

Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease

(2018) Courtney L. Sutphen et al.   Alzheimers & Dementia

CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

(2018) Oskar Hansson et al.   Alzheimers & Dementia

Haplotype analysis of APOE intragenic SNPs

(2018) Vladimir N. Babenko et al.   BMC NEUROSCIENCE

Brain properties predict proximity to symptom onset in sporadic Alzheimer’s disease

(2018) Jacob W Vogel et al.   BRAIN

Genetic study of multimodal imaging Alzheimer’s disease progression score implicates novel loci

(2018) Marzia A Scelsi et al.   BRAIN

Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer’s Disease Pathogenesis

(2018) Pierre-François Meyer et al.   JOURNAL OF ALZHEIMERS DISEASE

Effect of Education on Alzheimer’s Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer’s Disease: A Cross-Sectional Study

(2018) Masataka Wada et al.   JOURNAL OF ALZHEIMERS DISEASE

A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer’s Disease and Mild Cognitive Impairment

(2018) Hua Wang et al.   JOURNAL OF ALZHEIMERS DISEASE

Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment

(2018) Kelsey R. Thomas et al.   JOURNAL OF ALZHEIMERS DISEASE

The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1

(2018) Qi Wang et al.   JOURNAL OF ALZHEIMERS DISEASE

Do Cardiometabolic Risk Factors Influence Amyloid, Tau, and Neuronal Function in APOE4 Carriers and Non-Carriers in Alzheimer’s Disease Trajectory?

(2018) Grazia Daniela Femminella et al.   JOURNAL OF ALZHEIMERS DISEASE

Early Tau Burden Correlates with Higher Rate of Atrophy in Transentorhinal Cortex

(2018) Long Xie et al.   JOURNAL OF ALZHEIMERS DISEASE

MRI-Based Screening of Preclinical Alzheimer’s Disease for Prevention Clinical Trials

(2018) Adrià Casamitjana et al.   JOURNAL OF ALZHEIMERS DISEASE

Statistical Model of Dynamic Markers of the Alzheimer’s Pathological Cascade

(2018) Steve Balsis et al.   JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES

The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders

(2018) Susana Carmona et al.   LANCET NEUROLOGY

Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake

(2018) Sandhitsu R. Das et al.   NEUROBIOLOGY OF AGING

Memory decline accompanies subthreshold amyloid accumulation

(2018) Susan M. Landau et al.   NEUROLOGY

Dissociable influences ofAPOEε4 and polygenic risk of AD dementia on amyloid and cognition

(2018) Tian Ge et al.   NEUROLOGY

Resistance vs resilience to Alzheimer disease

(2018) Eider M. Arenaza-Urquijo et al.   NEUROLOGY

Word-list intrusion errors predict progression to mild cognitive impairment.

(2018) Kelsey R. Thomas et al.   NEUROPSYCHOLOGY

The development of a stochastic mathematical model of Alzheimer’s disease to help improve the design of clinical trials of potential treatments

(2018) Christoforos Hadjichrysanthou et al.   PLoS One

Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer’s disease

(2018) Dongwha Sohn et al.   Scientific Reports

Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study

(2018) Vijay R. Varma et al.   PLOS MEDICINE

Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau

(2018) Timothy J. Hohman et al.   JAMA Neurology

Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis

(2018) Liana G. Apostolova et al.   JAMA Neurology

Defining SNAP by cross-sectional and longitudinal definitions of neurodegeneration

(2018) L.E.M. Wisse et al.   NeuroImage-Clinical

Pre-amyloid stage of Alzheimer's disease in cognitively normal individuals

(2018) Betty M. Tijms et al.   Annals of Clinical and Translational Neurology

Prominent Non-Memory Deficits in Alzheimer’s Disease Are Associated with Faster Disease Progression

(2018) Nienke M.E. Scheltens et al.   JOURNAL OF ALZHEIMERS DISEASE

Reproducible evaluation of classification methods in Alzheimer's disease: Framework and application to MRI and PET data

(2018) Jorge Samper-González et al.   NEUROIMAGE

A ‘Comprehensive Visual Rating Scale’ for predicting progression to dementia in patients with mild cognitive impairment

(2018) Jae-Won Jang et al.   PLoS One

Structural brain imaging in Alzheimer’s disease and mild cognitive impairment: biomarker analysis and shared morphometry database

(2018) Christian Ledig et al.   Scientific Reports

Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer’s disease: a longitudinal cohort study

(2018) Roy W. E. Van Hooren et al.   Alzheimers Research & Therapy

Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms

(2018) Sebastian Palmqvist et al.   Alzheimers & Dementia

Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative

(2018) Dallas P. Veitch et al.   Alzheimers & Dementia

Development and Validation of a Dementia Risk Prediction Model in the General Population: An Analysis of Three Longitudinal Studies

(2018) Silvan Licher et al.   AMERICAN JOURNAL OF PSYCHIATRY

A δ Homolog for Dementia Case Finding with Replication in the Alzheimer’s Disease Neuroimaging Initiative

(2018) Donald R. Royall et al.   JOURNAL OF ALZHEIMERS DISEASE

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

(2018) Shubhabrata Mukherjee et al.   MOLECULAR PSYCHIATRY

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

(2018) Alexandra L Young et al.   Nature Communications

Prediction of Cerebral Amyloid With Common Information Obtained From Memory Clinic Practice

(2018) Jun Ho Lee et al.   Frontiers in Aging Neuroscience

Uncovering Biologically Coherent Peripheral Signatures of Health and Risk for Alzheimer’s Disease in the Aging Brain

(2018) Brandalyn C. Riedel et al.   Frontiers in Aging Neuroscience

Generation and quality control of lipidomics data for the alzheimer’s disease neuroimaging initiative cohort

(2018) Dinesh Kumar Barupal et al.   Scientific Data

Disease progression timeline estimation for Alzheimer's disease using discriminative event based modeling

(2018) Vikram Venkatraghavan et al.   NEUROIMAGE

Functional signature of conversion of patients with mild cognitive impairment

(2018) Stefano Delli Pizzi et al.   NEUROBIOLOGY OF AGING

Amyloid beta–positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity

(2018) Brian B. Avants et al.   NEUROBIOLOGY OF AGING

Cognitive Variability Predicts Incident Alzheimer’s Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker

(2017) Carey E. Gleason et al.   JOURNAL OF ALZHEIMERS DISEASE

In vivo staging of regional amyloid deposition

(2017) Michel J. Grothe et al.   NEUROLOGY

Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography

(2016) Sebastian Palmqvist et al.   BRAIN

The amyloid hypothesis of Alzheimer's disease at 25 years

(2016) Dennis J Selkoe et al.   EMBO Molecular Medicine

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

(2016) Clifford R. Jack et al.   NEUROLOGY

Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

(2016) Y. Iturria-Medina et al.   Nature Communications

Relative Citation Ratio (RCR): A New Metric That Uses Citation Rates to Measure Influence at the Article Level

(2016) B. Ian Hutchins et al.   PLOS BIOLOGY

Contributions of the Framingham Heart Study to the Epidemiology of Coronary Heart Disease

(2016) George Chen et al.   JAMA Cardiology

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014

(2015) Michael W. Weiner et al.   Alzheimers & Dementia

The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

(2015) William E. Klunk et al.   Alzheimers & Dementia

Cascading network failure across the Alzheimer’s disease spectrum

(2015) David T. Jones et al.   BRAIN

Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures

(2015) L. G. Apostolova et al.   NEUROLOGY

Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer’s Disease

(2015) Ashish Raj et al.   Cell Reports

Primary age-related tauopathy (PART): a common pathology associated with human aging

(2014) John F. Crary et al.   ACTA NEUROPATHOLOGICA

Sex differences in cognitive impairment and Alzheimer’s disease

(2014) Rena Li et al.   FRONTIERS IN NEUROENDOCRINOLOGY

Epidemic Spreading Model to Characterize Misfolded Proteins Propagation in Aging and Associated Neurodegenerative Disorders

(2014) Yasser Iturria-Medina et al.   PLoS Computational Biology

The Preclinical Alzheimer Cognitive Composite

(2014) Michael C. Donohue et al.   JAMA Neurology

Criteria for mild cognitive impairment due to alzheimer's disease in the community

(2013) Ronald C. Petersen et al.   ANNALS OF NEUROLOGY

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid

(2013) Susan M. Landau et al.   ANNALS OF NEUROLOGY

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

(2012) Susan M. Landau et al.   ANNALS OF NEUROLOGY

Risk prediction models: II. External validation, model updating, and impact assessment

(2012) Karel G M Moons et al.   HEART

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

(2011) Thomas J. Montine et al.   ACTA NEUROPATHOLOGICA

The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception

(2011) Michael W. Weiner et al.   Alzheimers & Dementia

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Relationships between biomarkers in aging and dementia

(2009) W. J. Jagust et al.   NEUROLOGY